Chapter/Section Purchase

1 Introduction to Research & Analysis Reports
1.1 Postoperative Nausea and Vomiting (PONV) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Postoperative Nausea and Vomiting (PONV) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Postoperative Nausea and Vomiting (PONV) Overall Market Size
2.1 Global Postoperative Nausea and Vomiting (PONV) Market Size: 2022 VS 2030
2.2 Global Postoperative Nausea and Vomiting (PONV) Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Postoperative Nausea and Vomiting (PONV) Players in Global Market
3.2 Top Global Postoperative Nausea and Vomiting (PONV) Companies Ranked by Revenue
3.3 Global Postoperative Nausea and Vomiting (PONV) Revenue by Companies
3.4 Top 3 and Top 5 Postoperative Nausea and Vomiting (PONV) Companies in Global Market, by Revenue in 2022
3.5 Global Companies Postoperative Nausea and Vomiting (PONV) Product Type
3.6 Tier 1, Tier 2 and Tier 3 Postoperative Nausea and Vomiting (PONV) Players in Global Market
3.6.1 List of Global Tier 1 Postoperative Nausea and Vomiting (PONV) Companies
3.6.2 List of Global Tier 2 and Tier 3 Postoperative Nausea and Vomiting (PONV) Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Postoperative Nausea and Vomiting (PONV) Market Size Markets, 2022 & 2030
4.1.2 Serotonin Antagonists
4.1.3 Steroids
4.1.4 Dopamine Antagonists
4.1.5 NK-1 Receptor Antagonists
4.1.6 Non-pharmacologic Treatment
4.1.7 Others
4.2 By Type - Global Postoperative Nausea and Vomiting (PONV) Revenue & Forecasts
4.2.1 By Type - Global Postoperative Nausea and Vomiting (PONV) Revenue, 2018-2023
4.2.2 By Type - Global Postoperative Nausea and Vomiting (PONV) Revenue, 2024-2030
4.2.3 By Type - Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Postoperative Nausea and Vomiting (PONV) Market Size, 2022 & 2030
5.1.2 Hospital Pharmacies
5.1.3 Online Pharmacies
5.1.4 Retail Pharmacies
5.2 By Application - Global Postoperative Nausea and Vomiting (PONV) Revenue & Forecasts
5.2.1 By Application - Global Postoperative Nausea and Vomiting (PONV) Revenue, 2018-2023
5.2.2 By Application - Global Postoperative Nausea and Vomiting (PONV) Revenue, 2024-2030
5.2.3 By Application - Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Postoperative Nausea and Vomiting (PONV) Market Size, 2022 & 2030
6.2 By Region - Global Postoperative Nausea and Vomiting (PONV) Revenue & Forecasts
6.2.1 By Region - Global Postoperative Nausea and Vomiting (PONV) Revenue, 2018-2023
6.2.2 By Region - Global Postoperative Nausea and Vomiting (PONV) Revenue, 2024-2030
6.2.3 By Region - Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Postoperative Nausea and Vomiting (PONV) Revenue, 2018-2030
6.3.2 US Postoperative Nausea and Vomiting (PONV) Market Size, 2018-2030
6.3.3 Canada Postoperative Nausea and Vomiting (PONV) Market Size, 2018-2030
6.3.4 Mexico Postoperative Nausea and Vomiting (PONV) Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Postoperative Nausea and Vomiting (PONV) Revenue, 2018-2030
6.4.2 Germany Postoperative Nausea and Vomiting (PONV) Market Size, 2018-2030
6.4.3 France Postoperative Nausea and Vomiting (PONV) Market Size, 2018-2030
6.4.4 U.K. Postoperative Nausea and Vomiting (PONV) Market Size, 2018-2030
6.4.5 Italy Postoperative Nausea and Vomiting (PONV) Market Size, 2018-2030
6.4.6 Russia Postoperative Nausea and Vomiting (PONV) Market Size, 2018-2030
6.4.7 Nordic Countries Postoperative Nausea and Vomiting (PONV) Market Size, 2018-2030
6.4.8 Benelux Postoperative Nausea and Vomiting (PONV) Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Postoperative Nausea and Vomiting (PONV) Revenue, 2018-2030
6.5.2 China Postoperative Nausea and Vomiting (PONV) Market Size, 2018-2030
6.5.3 Japan Postoperative Nausea and Vomiting (PONV) Market Size, 2018-2030
6.5.4 South Korea Postoperative Nausea and Vomiting (PONV) Market Size, 2018-2030
6.5.5 Southeast Asia Postoperative Nausea and Vomiting (PONV) Market Size, 2018-2030
6.5.6 India Postoperative Nausea and Vomiting (PONV) Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Postoperative Nausea and Vomiting (PONV) Revenue, 2018-2030
6.6.2 Brazil Postoperative Nausea and Vomiting (PONV) Market Size, 2018-2030
6.6.3 Argentina Postoperative Nausea and Vomiting (PONV) Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Postoperative Nausea and Vomiting (PONV) Revenue, 2018-2030
6.7.2 Turkey Postoperative Nausea and Vomiting (PONV) Market Size, 2018-2030
6.7.3 Israel Postoperative Nausea and Vomiting (PONV) Market Size, 2018-2030
6.7.4 Saudi Arabia Postoperative Nausea and Vomiting (PONV) Market Size, 2018-2030
6.7.5 UAE Postoperative Nausea and Vomiting (PONV) Market Size, 2018-2030
7 Postoperative Nausea and Vomiting (PONV) Companies Profiles
7.1 Acacia Pharma
7.1.1 Acacia Pharma Company Summary
7.1.2 Acacia Pharma Business Overview
7.1.3 Acacia Pharma Postoperative Nausea and Vomiting (PONV) Major Product Offerings
7.1.4 Acacia Pharma Postoperative Nausea and Vomiting (PONV) Revenue in Global Market (2018-2023)
7.1.5 Acacia Pharma Key News & Latest Developments
7.2 F. Hoffmann-La Roche
7.2.1 F. Hoffmann-La Roche Company Summary
7.2.2 F. Hoffmann-La Roche Business Overview
7.2.3 F. Hoffmann-La Roche Postoperative Nausea and Vomiting (PONV) Major Product Offerings
7.2.4 F. Hoffmann-La Roche Postoperative Nausea and Vomiting (PONV) Revenue in Global Market (2018-2023)
7.2.5 F. Hoffmann-La Roche Key News & Latest Developments
7.3 Novartis
7.3.1 Novartis Company Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis Postoperative Nausea and Vomiting (PONV) Major Product Offerings
7.3.4 Novartis Postoperative Nausea and Vomiting (PONV) Revenue in Global Market (2018-2023)
7.3.5 Novartis Key News & Latest Developments
7.4 Ani Pharmaceuticals
7.4.1 Ani Pharmaceuticals Company Summary
7.4.2 Ani Pharmaceuticals Business Overview
7.4.3 Ani Pharmaceuticals Postoperative Nausea and Vomiting (PONV) Major Product Offerings
7.4.4 Ani Pharmaceuticals Postoperative Nausea and Vomiting (PONV) Revenue in Global Market (2018-2023)
7.4.5 Ani Pharmaceuticals Key News & Latest Developments
7.5 Camurus
7.5.1 Camurus Company Summary
7.5.2 Camurus Business Overview
7.5.3 Camurus Postoperative Nausea and Vomiting (PONV) Major Product Offerings
7.5.4 Camurus Postoperative Nausea and Vomiting (PONV) Revenue in Global Market (2018-2023)
7.5.5 Camurus Key News & Latest Developments
7.6 Sanofi
7.6.1 Sanofi Company Summary
7.6.2 Sanofi Business Overview
7.6.3 Sanofi Postoperative Nausea and Vomiting (PONV) Major Product Offerings
7.6.4 Sanofi Postoperative Nausea and Vomiting (PONV) Revenue in Global Market (2018-2023)
7.6.5 Sanofi Key News & Latest Developments
7.7 Helsinn Holding
7.7.1 Helsinn Holding Company Summary
7.7.2 Helsinn Holding Business Overview
7.7.3 Helsinn Holding Postoperative Nausea and Vomiting (PONV) Major Product Offerings
7.7.4 Helsinn Holding Postoperative Nausea and Vomiting (PONV) Revenue in Global Market (2018-2023)
7.7.5 Helsinn Holding Key News & Latest Developments
7.8 Eisai
7.8.1 Eisai Company Summary
7.8.2 Eisai Business Overview
7.8.3 Eisai Postoperative Nausea and Vomiting (PONV) Major Product Offerings
7.8.4 Eisai Postoperative Nausea and Vomiting (PONV) Revenue in Global Market (2018-2023)
7.8.5 Eisai Key News & Latest Developments
7.9 Merck
7.9.1 Merck Company Summary
7.9.2 Merck Business Overview
7.9.3 Merck Postoperative Nausea and Vomiting (PONV) Major Product Offerings
7.9.4 Merck Postoperative Nausea and Vomiting (PONV) Revenue in Global Market (2018-2023)
7.9.5 Merck Key News & Latest Developments
7.10 GlaxoSmithKline
7.10.1 GlaxoSmithKline Company Summary
7.10.2 GlaxoSmithKline Business Overview
7.10.3 GlaxoSmithKline Postoperative Nausea and Vomiting (PONV) Major Product Offerings
7.10.4 GlaxoSmithKline Postoperative Nausea and Vomiting (PONV) Revenue in Global Market (2018-2023)
7.10.5 GlaxoSmithKline Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer